Einstein/Montefiore Department of Medicine

Grand Rounds

The Microbiome in Inflammatory Bowel Disease and Beyond

Einstein/Montefiore Department of Medicine Grand Rounds

Thursday, October 01, 2015

8:00 AM: Forchheimer Medical Science Building Conference Room 351

Speaker & Info

Dana Lukin, MD
Assistant Professor, Department of Medicine (Gastroenterology & Liver Diseases)
Director, Einstein-Montefiore Program for Inflammatory Bowel Diseases
Montefiore Einstein

Repeated at 12:15 pm, Cherkasky Auditorium, Montefiore Medical Center.

Dr. Dana Lukin specializes in the care of patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. He completed medical and graduate training as well as residency in internal medicine at Mount Sinai School of Medicine, followed by fellowship training in gastroenterology at Columbia University Medical Center.

Dr. Lukin works closely with colleagues in affiliated specialties in order to provide comprehensive care for IBD patients as the Director of the Einstein- Montefiore Program for Inflammatory Bowel Diseases. He serves on the Chapter Medical Advisory Committee (CMAC) for the New York Chapter of the Crohn's and Colitis Foundation of America (CCFA) as well as the CCFA Fellow's Committee. He is a founding member of IBD-REMEDY (REsearch Mentoring EDucation new York) and serves on the Executive Committee of the New York Crohn's and Colitis Organization (NYCCO).

With interests in clinical and translational research in IBD, Dr. Lukin is participating in several phase II and phase III Crohn's disease and ulcerative colitis trials. His current translational research focuses on the microbiome in IBD as well as the role of indoles in intestinal permeability and signaling through the pregnane X receptor (PXR) and TLR4, funded by a pilot grant from the CCFA-Broad Medical Research Program.

Objectives - After attending this activity, participants will be able to:

  1. Understand the historical associations of the microbiome and human disease
  2. Identify factors affecting the human microbiome in health and disease
  3. Understand the impact of the microbiome in various diseases
  4. Discuss potential therapies used to manipulate the microbiome in order to affect disease outcomes

Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.

Host: Department of Medicine (Division of Gastroenterology & Liver Diseases)

Contact Us

Department of Medicine
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
Belfer Building - Room 1008
1300 Morris Park Avenue
Bronx, NY 10461 (directions)

Physicians and Patients:
866-MED-TALK (866-633-8255)

Internal Medicine Residency Program:

Administrative Questions:
Fax: 718-430-8659

Click here to log in